Also, CCL2, which is elevated in neurons by pretreatment with FTY720 and implicated in the development of an ischemia tolerant phenotype in stroke models, is shown to be deleterious when expressed by reactive astrocytes in MS models (76). This evidence concerns the gene CCL2 and stroke disorder.